The gut endocrine system as a coordinator of postprandial nutrient homoeostasis

Proceedings of the Nutrition Society

Volumn 71, Issue 4, 2012, Pages 456-462

  Gribble, Fiona M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cholecystokinin; Diabetes; Enteroendocrine; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; Obesity

Indexed keywords

CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 2; PROTEIN TAG;

CARBOHYDRATE METABOLISM; CONFERENCE PAPER; DIGESTION; ENTEROENDOCRINE CELL; FAT INTAKE; HOMEOSTASIS; HORMONE RELEASE; LARGE INTESTINE; NONHUMAN; NUTRIENT CYCLING; POSTPRANDIAL STATE; PROTEIN HYDROLYSIS; PROTEIN SECRETION; SMALL INTESTINE;

ANIMALS; CHOLECYSTOKININ; DIABETES MELLITUS, TYPE 2; EATING; ENTEROENDOCRINE CELLS; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; OBESITY; POSTPRANDIAL PERIOD; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84868293826     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665112000705     Document Type: Conference Paper

References (72)

1. Baggio LL & Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157.
2. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409-1439.
3. Batterham RL & Bloom SR (2003) The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 994, 162-168.
4. Dockray GJ (2009) Cholecystokinin and gut-brain signalling. Regul Pept 155, 6-10.
5. Drucker DJ & Nauck MA (2006) The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705.
6. Karra E, Yousseif A & Batterham RL (2010) Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21, 337-344.
7. Tam CS, Berthoud HR, Bueter M et al (2011) Could the mechanisms of bariatric surgery hold the key for novel therapies? Report from a Pennington Scientific Symposium. Obes Rev 12, 984-994.
8. Thaler JP & Cummings DE (2009) Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150, 2518-2525.
9. Sjölund K, Sandén G, Håkanson R et al. (1983) Endocrine cells in human intestine: An immunocytochemical study. Gastroenterology 85, 1120-1130.
10. Eissele R, Goke R, Willemer S et al. (1992) Glucagon-like peptide-1 cells in the gastrointestinal-tract and pancreas of rat, pig and man. Eur J Clin Invest 22, 283-291.
11. Habib AM, Richards P, Cairns LS et al. (2012) Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153, 3054-3065.
12. Li HJ, Ray SK, Singh NK et al. (2011) Basic helix-loop-helix transcription factors and enteroendocrine cell differentiation. Diabetes Obes Metab 13 Suppl 1, 5-12.
13. May CL & Kaestner KH (2010) Gut endocrine cell development. Mol Cell Endocrinol 323, 70-75.
14. Pilichiewicz AN, Chaikomin R, Brennan IM et al. (2007) Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 293, E743-E753.
15. Pilichiewicz AN, Papadopoulos P, Brennan IM et al. (2007) Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 293, R2170-R2178.
16. Elliott RM, Morgan LM, Tredger JA et al. (1993) Glucagonlike peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man - acute postprandial and 24-h secretion patterns. J Endocrinol 138, 159-166.
17. Herrmann C, Goke R, Richter G et al. (1995) Glucagon-like peptide-1 and glucose dependent insulin-releasing polypeptide plasma-levels in response to nutrients. Digestion 56, 117-126.
18. Pilichiewicz AN, Little TJ, Brennan IM et al. (2006) Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 290, R668-R677.
19. Hall WL, Millward DJ, Long SJ et al. (2003) Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 89, 239-248.
20. Hira T, Mochida T, Miyashita K et al. (2009) GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats. Am J Physiol Gastrointest Liver Physiol 297, G663-G671.
21. Roberge JN, Gronau KA & Brubaker PL (1996) Gastrinreleasing peptide is a novel mediator of proximal nutrientinduced proglucagon-derived peptide secretion from the distal gut. Endocrinology 137, 2383-2388.
22. Rocca AS & Brubaker PL (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140, 1687-1694.
23. Roberge JN & Brubaker PL (1993) Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133, 233-240.
24. Hansen L & Holst JJ (2002) The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodenoYileal loop? Regul Pept 110, 39-45.
25. Schirra J, Katschinski M, Weidmann C et al. (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97, 92-103.
26. Chaikomin R, Wu KL, Doran S et al. (2008) Effects of midjejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men. Regul Pept 150, 38-42.
27. Little TJ, Doran S, Meyer JH et al. (2006) The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291, E647-E655.
28. Beglinger S, Drewe J, Schirra J et al. (2010) Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion. J Clin Endocrinol Metab 95, 879-886.
29. Enç F Y, Imeryüz N, Akin L et al. (2001) Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol Gastrointest Liver Physiol 281, G752-G763.
30. Hücking K, Kostic Z, Pox C et al. (2005) alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Diabet Med 22, 470-476.
31. Qualmann C, Nauck MA, Holst JJ et al. (1995) Glucagonlike peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alphaglucosidase inhibition (acarbose). Scand J Gastroenterol 30, 892-896.
32. Enç, F Y, Ones T, Akin HL et al. (2009) Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 296, G482-G489.
33. Layer P, Holst JJ, Grandt D et al. (1995) Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 40, 1074-1082.
34. Unger RH, Ohneda A, Valverde I et al. (1968) Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest 47, 48-65.
35. Jang HJ, Kokrashvili Z, Theodorakis MJ et al. (2007) Gutexpressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 104, 15069-15074.
36. Margolskee RF, Dyer J, Kokrashvili Z et al. (2007) T1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1. Proc Natl Acad Sci USA 104, 15075-15080.
37. Reimann F, Habib AM, Tolhurst G et al. (2008) Glucose sensing in L cells: A primary cell study. Cell Metab 8, 532-539.
38. Ma J, Bellon M, Wishart JM et al. (2009) Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 296, G735-G739.
39. Fujita Y, Wideman RD, Speck M et al. (2009) Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab 296, E473-E479.
40. Shima K, Suda T, Nishimoto K et al. (1990) Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops. Acta Endocrinol (Copenh) 123, 464-470.
41. Ritzel U, Fromme A, Ottleben M et al. (1997) Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol 34, 18-21.
42. Sykes S, Morgan LM, English J et al. (1980) Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. J Endocrinol 85, 201-207.
43. Gribble FM, Williams L, Simpson AK et al. (2003) A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52, 1147-1154.
44. Gorboulev V, Schürmann A, Vallon V et al. (2012) Na( + )-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187-196.
45. Hansen L, Hartmann B, Mineo H et al. (2004) Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regul Pept 118, 11-18.
46. Kuo P, Wishart JM, Bellon M et al. (2010) Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans. J Clin Endocrinol Metab 95, 3893-3900.
47. Parker HE, Adriaenssens A, Rogers GJ et al. (2012) Predominant role of active versus facilitative glucose transport For glucagon-like peptide-1 secretion. Diabetologia (Epublication ahead of print).
48. Cani PD, Holst JJ, Drucker DJ et al. (2007) GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Mol Cell Endocrinol 276, 18-23.
49. Lindgren O, Carr RD, Deacon CF et al. (2011) Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab 96, 2519-2524.
50. Briscoe CP, Tadayyon M, Andrews JL et al. (2003) The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278, 11303-11311.
51. Hirasawa A, Tsumaya K, Awaji T et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11, 90-94.
52. Overton HA, Babbs AJ, Doel SM et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3, 167-175.
53. Iakoubov R, Izzo A, Yeung A et al. (2007) Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148, 1089-1098.
54. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F and Gribble FM (2011) Molecular mechanisms underlying bile acid stimulated glucagon-like peptide-1 secretion. Br J Pharmacol 165, 414-423.
55. Thomsen C, Storm H, Holst JJ et al. (2003) Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr 77, 605-611.
56. Feltrin KL, Little TJ, Meyer JH et al. (2004) Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 287, R524-R533.
57. Edfalk S, Steneberg P & Edlund H (2008) Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57, 2280-2287.
58. Liou AP, Lu X, Sei Y et al. (2011) The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acidinduced secretion of cholecystokinin. Gastroenterology 140, 903-912.e904.
59. Iakoubov R, Ahmed A, Lauffer LM et al. (2011) Essential role for protein kinase Cz in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology 152, 1244-1252.
60. Hansen KB, Rosenkilde MM, Knop FK et al. (2011) 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 96, E1409-1417.
61. Schwartz GJ, Fu J, Astarita G et al. (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8, 281-288.
62. Simpson AK, Ward PS, Wong KY et al. (2007) Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia 50, 2181-2189.
63. Islam D, Zhang N, Wang P et al. (2009) Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alphaand intestinal L-cell lines. Am J Physiol Endocrinol Metab 296, E174-E181.
64. Drucker DJ, Jin TR, Asa SL et al. (1994) Activation of proglucagon gene-transcription by protein kinase-A in a novel mouse enteroendocrine cell-line. Mol Endocrinol 8, 1646-1655.
65. Liou AP, Sei Y, Zhao X et al. (2011) The extracellular calcium sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol 300, G538-546.
66. Mace OJ, Schindler M & Patel S (2012) The regulation of K- and L-cell activity by GLUT2 and CasR in rat small intestine. J Physiol 590, 2917-2936.
67. Reimann F, Williams L, Xavier GD et al. (2004) Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia. 47, 1592-1601.
68. Tolhurst G, Zheng Y, Parker HE et al. (2011) Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2 + and cAMP. Endocrinology 152, 405-413.
69. Liou AP, Chavez DI, Espero E et al. (2011) Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. Am J Physiol Gastrointest Liver Physiol 300, G895-G902.
70. Matsumura K, Miki T, Jhomori T et al. (2005) Possible role of PEPT1 in gastrointestinal hormone secretion. Biochem Biophys Res Commun 336, 1028-1032.
71. Coté G.A. & Edmundowicz SA (2009) Emerging technology: Endoluminal treatment of obesity. Gastrointest Endosc 70, 991-999.
72. Peterli R, Steinert RE, Woelnerhanssen B et al. (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: A randomized, prospective trial. Obes Surg 22, 740-748.